Susquehanna Fundamental Investments’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Susquehanna Fundamental Investments's CNST Position: Q3 2021 in Review

Susquehanna Fundamental Investments sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 22,252 shares — an estimated $752K sold.

Susquehanna Fundamental Investments first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $752K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

• Susquehanna Fundamental Investments reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
• Susquehanna Fundamental Investments sold 22,252 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $752K.
• Susquehanna Fundamental Investments first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
• Susquehanna Fundamental Investments's Constellation Pharmaceuticals, Inc. position peaked at $752K in Q2 2021.
• 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2021, filed 15 Nov 2021.